Point Therapeutics
Latest round
- Series B
Last raised
- Jul 2001
Total raised
- $5.4M
Investors
- 1
About Point Therapeutics
Point Therapeutics is a privately held biotechnology company focusing on developing therapeutics for the treatment of cancer and hematopoietic disorders.
Who invested in Point Therapeutics
1 investor across 1 round
See all investors in Point Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jul 1, 2001
Amount
$5.4M
Investors
Questions about Point Therapeutics
Who invested in Point Therapeutics?
Point Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Point Therapeutics raised?
Point Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Point Therapeutics last raise money?
Point Therapeutics's most recent round on record is a Series B, in Jul 2001.
What does Point Therapeutics do?
Point Therapeutics is a privately held biotechnology company focusing on developing therapeutics for the treatment of cancer and hematopoietic disorders.
Where is Point Therapeutics headquartered?
Point Therapeutics is headquartered in US.
Which VCs invest in companies like Point Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Point Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Point Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.